The Kay Hagan Tick Reauthorization Act (S. 2398) is a bill that aims to continue federal efforts to combat diseases spread by ticks and other vectors. It proposes extending funding for programs that support research centers specializing in vector-borne diseases and provides grants to state and local health departments to enhance their capacity to prevent and respond to these diseases. The bill seeks to authorize $30 million annually from 2026 through 2030 for these initiatives.
S. 2398 was introduced in the 119th Congress by Susan Collins (Republican) and is currently listed as “Enacted — Signed by President”. It is classified under the Health policy area, one of 508 bills in that area we track this Congress.
Susan Collins is the sponsor of 5 bills in our database this Congress, so S. 2398 is part of a broader legislative agenda rather than a one-off proposal.
Our conflict-of-interest analysis rates S. 2398 2/10 (low risk), higher than 76% of analyzed bills; the average in Health is 3.9/10.
Media coverage has highlighted the bill's commitment to addressing the growing public health threat posed by tick-borne diseases. The reauthorization is seen as a proactive measure to ensure continued research and support for health departments, which is crucial given the increasing incidence of diseases like Lyme disease. The bipartisan support for the bill underscores its importance in safeguarding public health.
Critics have expressed concerns about the bill's financial implications, questioning whether the allocated $30 million per year is sufficient to effectively combat the rising prevalence of tick-borne diseases. Some argue that without a significant increase in funding or new strategies, the reauthorization may not lead to substantial improvements in disease prevention and response.
The analysis of the Kay Hagan Tick Reauthorization Act, sponsored by Susan Collins, reveals no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries. This indicates a low risk of conflicts of interest as the financial interests of Collins' donors do not appear to influence the legislation. The absence of overlapping industries suggests that the motivations behind the bill are likely aligned with public health interests rather than donor agendas. Voters should be aware that while campaign contributions can sometimes lead to conflicts, in this case, the data does not support such a concern.
What does S. 2398 do?
The Kay Hagan Tick Reauthorization Act (S. 2398) is a bill that aims to continue federal efforts to combat diseases spread by ticks and other vectors. It proposes extending funding for programs that support research centers specializing in vector-borne diseases and provides grants to state and local health departments to enhance their capacity to prevent and respond to these diseases. The bill…
Has S. 2398 received a floor vote?
No roll-call vote on S. 2398 is recorded in our database yet. Its current status is “Enacted — Signed by President”.
Does S. 2398 have a conflict of interest?
Our conflict-of-interest analysis rates S. 2398 2/10 (low risk), higher than 76% of analyzed bills; the average in Health is 3.9/10. This score reflects overlap between the sponsor’s campaign funding, lobbying activity, and the industries the bill affects. It is a transparency indicator, not an accusation.
What is the status of S. 2398?
S. 2398 is currently “Enacted — Signed by President” as of our last update on October 2, 2026.
Who sponsored S. 2398?
S. 2398 was sponsored by Susan Collins (Republican).
